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ABSTRACT  
Aims: Female reproductive history has been inconsistently associated with risk of type 2 diabetes. 
We examined the prospective associations between aspects of a womans reproductive history and 
incident diabetes.   
Methods: This study pooled 126,721 middle-aged womens individual data from eight cohort 
studies contributing to the International Collaboration for a Life Course Approach to Reproductive 
Health and Chronic Disease Events (InterLACE). Associations between age at menarche, age at 
first birth, parity and menopausal status with incident diabetes were examined using generalized 
linear mixed models with binomial distribution and robust variance. We stratified by body mass 
index (BMI) when there was evidence of a statistical interaction with BMI.  
Results: Over a median follow-up of 9 years, 4,073 cases of diabetes were reported. Non-linear 
associations with diabetes were observed for age at menarche, parity and age at first birth. 
Compared with menarche at age 13, menarche at 10 years was associated with 18% increased risk 
of diabetes (Relative Risk [RR] 1.18, 95% Confidence interval [95%CI]: 1.021.37) after adjusting 
for BMI. After stratifying by BMI, the increase risk was only observed in women with BMI >25 
kg/m
2
. A U-shape relation was observed between parity and risk of diabetes. Compared with pre-
/peri-menopausal women, women with a hysterectomy/oophorectomy had an increased risk of 
diabetes (RR 1.17, 95% CI: 1.071.29). 
Conclusions: Several markers of a womans reproductive history appear to be modestly associated 
with future risk of diabetes. Maintaining a normal weight in adult life may ameliorate any increase 
in risk conferred by early onset of menarche.    
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INTRODUCTION  
Both the incidence and prevalence of type 2 diabetes (referred to subsequently as diabetes) have 
increased considerably in recent decades with current estimates indicating that there are over 400 
million affected individuals worldwide.
1
 Overall similar numbers of women and men have diabetes, 
but age-adjusted rates tend to be greater for men than women 
1
. Diabetes confers significant health 
risks, in particular for vascular diseases, where the effect of diabetes appears to be more 
catastrophic in women than in men.
2-5
  
 
Although the ongoing epidemic of overweight and obesity has fuelled much of the observed 
increase in diabetes rates globally, there has been growing attention paid to a possibly aetiological 
role for female-specific markers of reproductive health - such as age at menarche, parity, and age at 
menopause - in the development of diabetes.
6-10
 Notable trends in the prevalence of female-specific 
risk factors such as an increase in the rate of gestational diabetes (itself, a major risk factor for 
diabetes) observed in populations,
11
 and a decline in the mean age of menarche 
12
 (in part due to the 
increase in childhood obesity) have added to the speculation that they may play a role in the 
diabetes pandemic.   
 
The question of whether age at menarche (which has been declining in high-income countries) is 
inversely associated with subsequent increased risk of diabetes has received much attention in 
recent years.
13,14
 But there is a lack of consistency in study findings 
15,16
 possibly due to differences 
in study designs and background rates of obesity and diabetes in the populations studied. 
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Quantification of any causal relationship is also hampered by the strong relationship that exists 
between excess body weight with both early menarche and diabetes.
8,15,17
  
 
In this study, we report on the associations between several female reproductive markers and 
subsequent incidence of diabetes. We also examine if the associations are explained by excess body 
size in midlife.  
 
METHODS 
Ethics  
Participants were recruited under the Institutional Review Board protocols approved at each of the 
research centres, and all study participants provided informed written consent. The details of the 
study ethics are described elsewhere.
18,19
 
 
Study participants  
This study pooled individual data from the International Collaboration for a Life Course Approach 
to Reproductive Health and Chronic Disease Events (InterLACE) study. Details of the InterLACE 
study aims, design and data harmonisation are presented elsewhere.
18,19
 In summary, InterLACE 
consisted of pooled data from 20 observational studies (12 of which were longitudinal) from ten 
countries. Participating studies provided self-reported survey data on a range of reproductive, 
sociodemographic and lifestyle variables. For this analysis, only studies that had information on 
selected reproductive characteristics and incident diabetes were included (Supplementary Table 
1). The numbers of women and exclusion criteria are presented in Figure 1. Womens average age 
at first (or baseline) survey ranged from 45 to 60 years in most studies except for two British birth 
cohorts where data from surveys at ages 47 (MRC National Survey of Health and Development) 
and 50 years (National Child Development Study) were considered as baseline for this study.  
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Measurement of markers of reproductive history  
Reproductive factors of interest were age at menarche, age at first birth, number of children (parity), 
menopausal status/timing, and hormone therapy at baseline. Age at menarche was by recall in all 
studies except for the two British birth cohort studies 
20,21
 and was categorised as  10, 11, 12, 13, 
14, 15, 16 and  17 years. Age at first birth for parous women was categorised as < 20, 20-24, 25-
29, 30-34 and  35 years.  Parity was categorised as no children, one child, two, three, and > four 
children. Menopausal status/timing at baseline was aggregated into seven categories based on 
menstrual bleeding patterns and history of gynaecological surgery: four categories of natural 
menopause (defined by amenorrhea for at least 12 months where this was not the result of an 
intervention; occurring before age 40, 40-44, 45-49 and  50 years), hysterectomy or 
oophorectomy, unknown status due to use of hormones (unless natural menopause is specified), and 
pre/peri-menopause (menstrual periods in the last 12 months). Use of menopausal hormone therapy 
(e.g., oestrogen) was categorised as never, past and current users.  
 
Body mass index and covariates  
Body mass index (BMI) (defined as weight in kilograms divided by height in meters squared) was 
self-reported or measured at study baseline, and was categorised as underweight (< 18.5 kg/m
2
), 
normal weight (18.5-24.9 kg/m
2
), overweight (25-29.9 kg/m
2
), and obese ( 30 kg/m2) 
according to the World Health Organisation classification.
22
In the multivariable analysis, the 
following covariates were included: womens year of birth (< 1940, 1940-49, 1950-59 and  1960), 
age at baseline (< 40, 40-49, 50-59, 60-69 and  70 years), years of education ( 10, 11-12 and > 12 
years), and smoking status (current, past and never smoker).  
 
Case ascertainment  
Physician-diagnosed diabetes was self-reported at baseline or follow-up surveys in most studies 
while two studies also collected diabetes information from hospital patient registry data (the Danish 
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Nurse Cohort Study and the Womens Lifestyle and Health Study).
23,24
 Diabetes reported at or 
before baseline were marked as prevalent diabetes and were excluded from the analysis. For women 
with no information on diabetes status at baseline, information from subsequent follow-up surveys 
was used. Only those reporting no diabetes for at least one post-baseline survey prior to reporting 
diabetes (for cases) or last follow up (non-cases) were included in the analysis to ensure exclusion 
of all potential prevalent cases (n = 2,124). Women who reported age of onset of diabetes below the 
age of 30 years (indicative of type 1 diabetes) were excluded.  
 
Statistical analyses 
Generalized linear mixed models with binomial distribution and logarithm link 
25
 were used to 
analyse the binary outcome of incident diabetes, and the relative risk (RR) and 95% confidence 
intervals (95% CI) estimates were obtained. Study level variability was included in the model as a 
random effect, while other exposures and confounding factors were modelled as fixed effects and 
the robust variance estimation method was used. Covariates that were potential confounders of the 
association between reproductive factors and diabetes were only adjusted for in the multivariable 
model. 
The relative risk of diabetes associated with each individual reproductive factor were assessed using 
three models: minimally adjusted for womens year of birth, baseline age, education and smoking 
status (model 1); further adjusted for other reproductive factors (model 2); and baseline BMI (model 
3). To investigate whether the association between reproductive factors and diabetes is modified by 
womens midlife BMI, we assessed statistical interactions between reproductive factors and BMI on 
diabetes outcome, and also estimated the associations stratified by two broad categories of BMI 
(normal weight: < 25 kg/m
2
, and overweight or obese:  25 kg/m2). 
 
Sensitivity analysis 
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To assess whether there was between-study heterogeneity in the associations and if any single study 
had undue influence on the overall association, we performed study-specific analyses and tested the 
heterogeneity in the study level estimates using random-effects meta-analysis.  
 
Further, we carried out a sensitivity analysis that restricted the study sample to only those women 
with at least five years of follow-up (n = 74,885). This is to allow for sufficient time for the 
development of diabetes following hysterectomy/oophorectomy and to minimise effect of 
unmeasured confounding factors (that is some pre-existing condition that both required a woman to 
have a hysterectomy/oophorectomy and which is also related to increased risk of diabetes). 
 
RESULTS 
Study characteristics 
A total of 126,721 women with complete history on the reproductive exposures and relevant 
covariates comprised the study sample for this analysis (Figure 1). Data were based on eight studies 
from four predominantly Caucasian populations: Australia, Denmark, Sweden and UK. The study 
name, country of origin and the number of observations used for each study are provided in 
Supplementary Table 1. Most women (72%) were born between 1940 and 1959 with only 4% 
born after 1960. The womens mean age at baseline survey was 48.6 years (SD 9.7 years) and mean 
age at last follow-up was 56.1 years (SD 11.4 years).  
 
A histogram showing the distribution of age at menarche in the study population is given in 
Supplementary Figure 1. The mean age at menarche was 13.1 years (median 13 years; range 8-20 
years) with 15% of women reporting menarche at  11 years. Three-quarters of women had > 2 
children, and a similar proportion had their first child birth before the age of 30. Virtually half 
(50.2%) of the participants were pre- or peri-menopausal at baseline, 2.5% had experienced early 
menopause (natural menopause before the age of 45 years), and 14% reported having had a 
This article is protected by copyright. All rights reserved.
A
cc
ep
te
d
 A
rt
ic
le
hysterectomy or oophorectomy. Age of natural menopause was unknown for about 14% of women 
taking menopausal hormone therapy. Details of the distribution of reproductive factors by studies 
are provided in Supplementary Table 2. 
 
Over a median follow-up of 9 years, 4,073 new cases of diabetes were ascertained. The crude 
incidence of diabetes was 4.3 per 1000 person-years, and the age-adjusted incidence rate was 4.6 
per 1000 person-years (ranged from 2.3 to 7.5 per 1000 person-years across the eight cohorts). The 
distribution of incident cases of diabetes according to age, sociodemographic indices, physiological 
and reproductive characteristics at study baseline are shown in Table 1. There were significant 
differences in the distribution of all of the aforementioned covariates between women with and 
without incident diabetes.  
 
Age at menarche and incident diabetes 
The association between age at menarche and incident diabetes was non-linear: there was evidence 
to suggest that only menarche at  11 years was associated with increased risk of diabetes compared 
to those women who were 13 years at onset of menarche (Table 2). Compared with women who 
were 13 years at onset of menarche, those who were  10 years had 68% increased risk of 
developing diabetes in later life (RR 1.68, 95% CI: 1.451.96) after adjusting for demographic and 
socio-economic factors. The strength of this association remained largely unaffected by adjustment 
for other reproductive markers while adjustment for BMI strongly attenuated the estimate (RR 1.18, 
95% CI: 1.021.37; Model 3, Table 2).   
 
Test for interaction indicated potential effect modification by BMI (p for interaction = 0.06): there 
was no association among women with BMI < 25 kg/m2 but a non-linear relation in women with 
BMI  25 kg/m2. In women with BMI  25 kg/m2, those who were aged  10 years at menarche 
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were at 33% increased risk of diabetes (RR 1.33, 95% CI: 1.131.55) compared with women who 
were 13 years of age at menarche (Table 3).  
 
Age at first birth, parity and incident diabetes 
There was a non-linear relationship between age at first birth with incident diabetes in the 
minimally-adjusted model (Table 2) that was ameliorated following adjustment for reproductive 
factors (Model 2) and midlife BMI (Model 3). The association between parity and incident diabetes 
was U-shaped and remained after adjustment for other reproductive factors and midlife BMI. 
Compared with women with two children, nulliparous women were at 18% increased risk of 
diabetes (RR 1.18, 95% CI: 1.061.31) , and women who had > 4 children were at 13% greater risk 
(RR 1.13, 95% CI: 1.031.24) (Model 3, Table 2). 
 
Menopausal status baseline, use of hormone replacement therapy and incident diabetes 
Compared with women who were pre/perimenopausal, there was an indication that women who 
reached menopause before the age of 40 had an elevated but not statistically significant risk of 
incident diabetes (RR 1.27, 95% CI: 0.911.76). (Table 2). Women who reported having had a 
hysterectomy/oophorectomy at baseline had a 17% increased risk of diabetes (RR 1.17, 95% CI: 
1.071.29) compared with pre/perimenopausal women after adjustment for other reproductive 
factors and midlife BMI. Findings from the sensitivity analysis, that restricted the study sample to 
only those women with at least five years of follow-up, were similar to the main results 
(Supplementary Table 3).  
 
Test for interaction indicated significant effect modification of the association between menopausal 
status and diabetes by BMI (p for interaction = 0.001). In BMI stratified analyses, the increased risk 
of diabetes associated with hysterectomy/oophorectomy remained but was stronger among women 
with BMI < 25 kg/m
2
 than those with BMI   25 kg/m2: RR 1.55, 95% CI: 1.271.91 vs RR 1.15, 
95% CI: 1.031.28 respectively; Table 3). 
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There was no evidence of an association between hormone therapy use (past or current user versus 
never) and incident diabetes (Table 2). 
 
 
Study-specific results 
The random-effects meta-analysis showed the study specific estimates to be broadly consistent for 
the following significant associations between markers of reproductive history and incident 
diabetes: age at menarche < 11 years vs 13 years (I
2
 = 18.6%, p = 0.28); having > 4 vs 2 children (I
2
 
= 0.9%, p = 0.42); and hysterectomy/oophorectomy vs. pre/perimenopause (I
2
 = 0.0%, p = 0.58) 
(Supplementary Figure 2). There was some evidence of between-study heterogeneity for the 
association between nulliparity and risk of diabetes that was contingent on the findings from two 
studies (I
2
 = 70.5%, p = 0.001). Following exclusion of these studies attenuated the magnitude of 
the between-study heterogeneity (I
2
 = 54.2%, p = 0.05). The study specific estimates were 
consistent but attenuated, after adjusting for midlife BMI (Supplementary Figure 3). 
 
DISCUSSION 
Findings from this collaboration of population-based cohort studies of womens health add to the 
accruing evidence that characteristics of a womans reproductive history may be associated with 
incident diabetes in later life. Consistent with previous studies 
13,14,26,27
 early menarche ( 11 years) 
was associated with a small increase in risk of diabetes compared to women who reported 
experiencing menarche at 13 years. However, our findings indicate that the effect is only apparent 
among women with a midlife BMI in the overweight or obese range. There are several ways to 
interpret this finding; it may indicate that remaining relatively lean throughout life effectively 
mitigates any excess risk conferred by early age at menarche. Alternatively, it may reflect a 
cumulative exposure to excess body weight beginning in early life: i.e. overweight women in adult 
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life were also overweight as children resulting in both early age at menarche and increased risk of 
diabetes in adult life. 
 
Most studies that have examined the relationship between age at menarche and risk of subsequent 
diabetes, in the absence of a measure of childhood weight, have used adult BMI as a proxy measure 
arguing that overweight and obesity tend to track throughout life (i.e., children who are overweight 
are significantly more likely to remain overweight throughout adulthood).
8,26
 This may be the case 
for contemporary birth cohorts but the studies included in the current collaboration included women 
who were born decades before the obesity epidemic in children. Hence, one would expect relatively 
few women to have been overweight or obese as children. The two largest studies to date, which 
have reported on the association between age at menarche and incident diabetes have shown 
conflicting results. In the EPIC-Interact study,
14
 the inverse association between age at menarche 
and the risk of diabetes persisted after adjustment for body mass index.  In contrast, in the Womens 
Health Initiative 
27
 - a large study of hormone replacement therapy in postmenopausal women - the 
inverse association between age at menarche and risk of diabetes was attenuated once adjustment 
was made for BMI in adult life (as we also found).  This discrepancy between these two large 
studies may be a birth cohort effect or due to the use of different categories for menarche age, and it 
would be of interest to know whether stratification by BMI in these studies would yield findings 
comparable to ours.  
 
In InterLACE, parity was nonlinearly associated with risk of diabetes such than compared to 
women with two children, both nulliparous women, and women with four or more children, were at 
increased risk of diabetes. The relationship  which was broadly consistent across the included 
studies - was independent of other reproductive risk factors and midlife BMI. These findings are 
consistent with other population based cohort studies where nulliparity or having four or more 
children were independently associated with greater risk of diabetes in later life.
28,29
  Our findings 
This article is protected by copyright. All rights reserved.
A
cc
ep
te
d
 A
rt
ic
le
contrast slightly with those of a recent meta-analysis of published results from seven studies. In that 
overview, although the association between parity and incident diabetes was non-linear, the authors 
aggregated the heterogeneous study estimates and presented a dose-response relationship such that 
for every live birth increase in parity the risk of diabetes increased by 6%.
30
 Although beyond the 
scope of these data, possible mechanistic explanations for this association include cumulative 
exposure to repeat periods of increased insulin resistance and pancreatic beta cell proliferation 
during pregnancy and subsequent beta cell dysfunction.
30
  
 
Women who had had either a hysterectomy or oophorectomy had a modest increased risk of 
diabetes that was robust to adjustment for potential confounders. These findings are consistent with 
those from both animal and epidemiological studies which indicate that oophorectomy and surgical 
menopause is associated with increased insulin resistance, metabolic disturbances and incident 
diabetes.
31
 In particular, two large prospective studies have shown an increased risk of incident 
diabetes following hysterectomy and/or oophorectomy in postmenopausal women.
32,33
 There was 
some evidence from our data that premature menopause (menopause by the age of 40 years) is 
related to risk of incident diabetes. The non-significant result may be due to lack of statistical 
power.  Previous studies have suggested that premature and early natural menopause are associated 
with subsequent risk of diabetes. 
34
 Most recently, data from the Rotterdam Study showed a three-
fold increased risk of diabetes for women who experienced premature menopause compared with 
those who experienced menopause after the age of 55 years  although the number of incident cases 
of diabetes in both groups (n = 29) was much smaller than in the current study. Previous authors 
have speculated on possible genetic mechanisms linking early age at menopause (possibly a proxy 
for premature ageing and DNA damage) with risk of incident diabetes and other chronic, age-
related conditions. 
34
 It remains to be determined by future studies whether early age at menopause 
predicts future health outcomes.  
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The strength of our study is the large pool of individual-level data that span several geographic 
regions. InterLACE harmonised variables using common definitions and provided sufficient 
heterogeneity and statistical power to examine the sub groups. There are several limitations to the 
current study that warrant brief discussion. Only the two birth cohorts 
20,21
 had a measure of 
childhood weight status, which meant that we were unable to adjust for its potential confounding 
effect in the analysis. However, given that approximately 95% of the participants were born before 
1960 (several decades before the childhood obesity epidemic commenced), we consider it unlikely 
that a significant proportion of these women was overweight in childhood and therefore the 
potential confounding effect to be minimal. The National Survey of Health and Development study 
that did have data on childhood weight supports this hypothesis; at age 11 years, less than 2% of the 
women were overweight or obese and this increased to 7% at age 15 years (data not shown). Age at 
menarche was predominantly based on recall; the error that this would have introduced is likely to 
have been non-differentially distributed across the cohorts and would have biased any associations 
towards the null. Diagnosis of diabetes was also largely by self-report which raises the possibility of 
misclassification of outcome; however, previous longitudinal cohort studies have indicated that self-
reported diabetes is more than 90% reliable of diabetes status over time
35
. Moreover, any 
misclassification of diabetes status is likely to be non-differentially distributed across the categories 
of age at menarche. Approximately 21% of observations were dropped in our complete case 
analysis due to missing data on covariates. When the missing data were imputed using multiple 
imputation and analysed (data not shown), we did not find overall difference in our estimates except 
for early age at menarche and early menopause which slightly improved suggesting slight 
underestimation of these factors. 
 
In summary, early age of menarche may be a risk factor for incident diabetes but it remains to be 
determined whether the effect is purely driven by early overweight and obesity tracking into adult 
life. Parity and a history of hysterectomy or oophorectomy appear to be related to incident diabetes 
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 although the effect sizes were modest and thus, the associations could still be due to residual 
confounding. In contrast, there was no clear evidence that use of hormone replacement therapy, age 
at natural menopause and age at which a woman has her first child are independently associated 
with risk of diabetes. Whether the relationships that we, and others, have observed between markers 
of reproductive health and incident diabetes are truly causal, and predictive of diabetes in later life, 
remain to be determined and subject to investigation by future studies.  
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Table 1. Baseline characteristics according to women with and without new onset type 2 diabetes   
 Incidence of diabetes  
Variable Categories 
No 
n (%) 
Yes 
n (%) P value
  122648 (96.8) 4073 (3.2) 
Womens year of birth <1940 29216 (23.8) 1289 (31.6) <0.0001
 1940-49 44962 (36.7) 1810 (44.4) 
 1950-59 43697 (35.6) 914 (22.4) 
 1960 4773 (3.9) 60 (1.5) 
    
Age (years) <40  21999 (17.9) 328 (8.1) <0.0001
 40-49  54803 (44.7) 2018 (49.5) 
 50-59  28142 (22.9) 933 (22.9) 
 60-69  15192 (12.4) 667 (16.4) 
 70  2512 (2.0) 127 (3.1) 
 Mean (SD) 48.5 (9.7) 51.0 (9.1) 
 Median (Q1, Q3) 47.3 (42.0, 54.0) 49.0 (46.0, 57.0) 
    
Education level (years)  10  41825 (34.1) 1903 (46.7) <0.0001
 11-12  18180 (14.8) 498 (12.2) 
 >12  62643 (51.1) 1672 (41.1) 
    
Body mass index (kg/m2) Underweight (<18.5) 2308 (1.9) 17 (0.4) <0.0001
 Normal (18.5-24.9) 77218 (63.0) 983 (24.1) 
 Overweight (25-29.9) 31210 (25.4) 1495 (36.7) 
 Obese (30) 11912 (9.7) 1578 (38.7) 
 Mean (SD) 24.4 (4.2) 29.2 (5.7) 
 Median (Q1, Q3)) 23.5 (21.5, 26.3) 28.5 (25.0, 32.5) 
    
Smoking status  Never smoker 60389 (49.2) 1961 (48.1) <0.0001
 Past smoker 38382 (31.3) 1157 (28.4) 
 Current smoker 23877 (19.5) 955 (23.4) 
    
Age at menarche (years) 10  3772 (3.1) 195 (4.8) <0.0001
 11  14271 (11.6) 620 (15.2) 
 12  25407 (20.7) 835 (20.5) 
 13  34375 (28.0) 1088 (26.7) 
 14  25349 (20.7) 741 (18.2) 
 15  12243 (10.0) 357 (8.8) 
 16  5098 (4.2) 151 (3.7) 
 17  2133 (1.7) 86 (2.1) 
 Mean (SD) 13.1 (1.5) 12.9 (1.6) 
 Median (Q1, Q3)) 13.0 (12.0, 14.0) 13.0 (12.0, 14.0) 
    
Number of children 0  15958 (13.0) 537 (13.2) <0.0001
 1  13754 (11.2) 406 (10.0) 
 2  50090 (40.8) 1434 (35.2) 
 3  29303 (23.9) 1036 (25.4) 
 4  13543 (11.0) 660 (16.2) 
    
Age at first birth (years)  No children 15958 (13.0) 537 (13.2) 
 <20   7130 (5.8) 366 (9.0) <0.0001
 20-24  39187 (32.0) 1435 (35.2) 
 25-29  40260 (32.8) 1146 (28.1) 
This article is protected by copyright. All rights reserved.
A
cc
ep
te
d
 A
rt
ic
le
 30-34  15038 (12.3) 444 (10.9) 
 35  5075 (4.1) 145 (3.6) 
 Mean (SD) 25.7 (4.6) 24.9 (4.7) 
 Median (Q1, Q3) 25.0 (23.0, 28.0) 24.0 (22.0, 28.0) 
    
Menopausal status and  Hysterectomy/oophorectomy  17045 (13.9) 870 (21.4) <0.0001
menopause timing (years) Natural menopause <40  641 (0.5) 34 (0.8) 
 Natural menopause 40-44  2331 (1.9) 108 (2.7) 
 Natural menopause 45-49  7255 (5.9) 286 (7.0) 
 Natural menopause 50   16140 (13.2) 625 (15.3) 
 Unknown due to hormone use  17302 (14.1) 481 (11.8) 
 Pre-/peri-menopause 61934 (50.5) 1669 (41.0) 
 Mean age at menopause (SD)* 49.9 (4.2) 50.2 (4.5) 
 Median age at menopause (Q1, Q3)* 50.0 (48.0, 53.0) 50.0 (48.0, 53.0) 
    
Hormone therapy  Never  97308 (79.3) 3051 (74.9) <0.0001
 Past  8369 (6.8) 369 (9.1)  
 Current 16971 (13.8) 653 (16.0)  
Abbreviation: SD, standard deviation; Q1  25 percentile; Q3  75 percentile.  
Data were presented as number (%), mean (SD), or median (Q1, Q3). 
*Mean and median age at menopause were only presented among women who had reached menopause at baseline (n = 
27,420).   
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Table 2. Adjusted relative risks of new onset type 2 diabetes associated with reproductive factors  
   
Model 1: Minimally 
adjusted 
Model 2: plus 
reproductive factors 
Model 3: plus  
 BMI 
Reproductive factors Categories n
Diabetes
case (%)
RR (95%CI) RR (95%CI) RR (95%CI) 
Age at menarche (years) 10  3,967 4.9 1.68 (1.45,1.96) 1.63 (1.40,1.89) 1.18 (1.02,1.37) 
 11  14,891 4.2 1.42 (1.28,1.56) 1.39 (1.26,1.54) 1.13 (1.03,1.24) 
 12  26,242 3.2 1.07 (0.97,1.17) 1.06 (0.97,1.16) 0.97 (0.89,1.06) 
 13  35,463 3.1 Reference  Reference  Reference 
 14  26,090  2.8 0.87 (0.80,0.96) 0.88 (0.80,0.96) 0.94 (0.86,1.03) 
 15 12,600 2.8 0.81 (0.72,0.92) 0.82 (0.72,0.92) 0.94 (0.84,1.06) 
 16  5,249 2.9 0.78 (0.66,0.93) 0.79 (0.67,0.94) 0.89 (0.75,1.05) 
 17  2,219 3.9 1.00 (0.81,1.25) 1.01 (0.81,1.26) 1.09 (0.88,1.35) 
     
Number of children 0  16,495 3.3 1.20 (1.08,1.33) 1.26 (1.13,1.41) 1.18 (1.06,1.31) 
1    14,160 2.9 1.08 (0.96,1.20) 1.06 (0.95,1.19) 1.05 (0.94,1.18) 
 2   51,524 2.8 Reference  Reference Reference 
 3  30,339 3.4 1.09 (1.01,1.18) 1.08 (1.00,1.18) 1.04 (0.96,1.12) 
 4  14,203 4.6 1.30 (1.19,1.43) 1.27 (1.15,1.40) 1.13 (1.03,1.24) 
     
Age at first birth (years) <20   7,496 4.9 1.36 (1.21,1.54) 1.21 (1.06,1.37) 1.09 (0.97,1.24) 
 20-24  40,622 3.5 1.14 (1.05,1.23) 1.08 (1.00,1.17) 1.04 (0.96,1.13) 
 25-29  41,406 2.8 Reference  Reference Reference 
 30-34  15,482 2.9 1.10 (0.98,1.22) 1.11 (0.99,1.24) 1.08 (0.97,1.20) 
 35  5,220 2.8 1.10 (0.92,1.31) 1.12 (0.94,1.34) 1.07 (0.90,1.28) 
     
Menopausal status and Hysterectomy/oophorectomy  17,915 4.9 1.35 (1.23,1.48) 1.31 (1.19,1.44) 1.17 (1.07,1.29) 
menopause timing (years) Natural menopause <40  675 5.0 1.40 (0.99,1.97) 1.33 (0.94,1.87) 1.27 (0.91,1.76) 
 Natural menopause 40-44  2,439 4.4 1.13 (0.92,1.39) 1.11 (0.90,1.36) 1.08 (0.88,1.32) 
 Natural menopause 45-49  7,541 3.8 1.03 (0.89,1.19) 1.02 (0.88,1.18) 0.96 (0.83,1.11) 
 Natural menopause 50  16,765 3.7 1.05 (0.92,1.18) 1.04 (0.91,1.17) 0.96 (0.85,1.09) 
 Unknown due to hormone use  17,783 2.7 0.94 (0.85,1.05) 0.96 (0.85,1.09) 1.00 (0.89,1.13) 
 Pre-/peri-menopause 63,603 2.6 Reference  Reference  Reference 
     
Hormone therapy  Never  100,359 3.0 Reference  Reference  Reference 
 Past  8,738 4.2 1.07 (0.95,1.21) 1.01 (0.90,1.14) 1.01 (0.90,1.13) 
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Model 1: Minimally 
adjusted 
Model 2: plus 
reproductive factors 
Model 3: plus  
 BMI 
Reproductive factors Categories n
Diabetes
case (%)
RR (95%CI) RR (95%CI) RR (95%CI) 
 Current 17,624 3.7 1.02 (0.93,1.12) 0.96 (0.86,1.08) 1.04 (0.92,1.16) 
Abbreviation: BMI, body mass index.  
Data were presented as relative risk (RR) and 95% confidence intervals (95% CI).   
Model 1 was adjusted for womens year of birth, age at baseline, education and smoking status at baseline. 
Model 2 was adjusted for covariates in model 1 plus age at menarche, number of children, age at first birth, menopausal status/timing and hormone therapy at baseline  
Model 3 was adjusted for covariates in model 2 plus baseline body mass index (BMI) (under/normal weight, overweight, and obese).  
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Table 3. Adjusted relative risks of new onset type 2 diabetes associated with reproductive factors stratified by baseline body mass index  
 
BMI < 25 kg/m
2
 
 (n = 80,526) 
BMI  25 kg/m2  
 (n = 46,195) 
Variable Categories n
Diabetes
case (%)
Fully adjusted*  
RR (95% CI) n 
Diabetes 
case (%)
Fully adjusted*  
RR (95% CI) 
Age at menarche (years) 10  1731 1.1 1.08 (0.67,1.73) 2236 7.9 1.33 (1.13,1.55) 
 11  7798 1.2 1.17 (0.92,1.49) 7093 7.4 1.19 (1.07,1.32) 
 12  15979 1.1 1.02 (0.84,1.24) 10263 6.4 0.98 (0.88,1.08) 
 13  23145 1.1 Reference 12318 6.7 Reference 
 14  17835 1.4 1.13 (0.95,1.35) 8255 6.0 0.86 (0.77,0.96) 
 15 8901 1.4 1.06 (0.85,1.31) 3699 6.3 0.85 (0.74,0.98) 
 16  3604 1.5 1.05 (0.78,1.41) 1645 5.9 0.80 (0.65,0.99) 
 17  1533 1.8 1.15 (0.78,1.71) 686 8.5 1.09 (0.84,1.41) 
    
Menopausal status and Hysterectomy/oophorectomy  9498 2.1 1.55 (1.27,1.91) 8417 8.0 1.15 (1.03,1.28) 
menopause timing (years) Natural menopause <40  341 1.8 1.64 (0.71,3.77) 334 8.4 1.23 (0.85,1.78) 
 Natural menopause 40-44  1256 1.9 1.31 (0.84,2.04) 1183 7.1 1.02 (0.81,1.29) 
 Natural menopause 45-49  4137 1.6 1.15 (0.85,1.56) 3404 6.5 0.95 (0.81,1.12) 
 Natural menopause 50  9060 1.6 1.17 (0.90,1.51) 7705 6.3 0.94 (0.82,1.08) 
 Unknown due to hormone use  12421 1.2 1.03 (0.81,1.31) 5362 6.2 0.98 (0.85,1.13) 
 Pre-/peri-menopause 43813 0.9 Reference 19790 6.3 Reference 
Abbreviation: BMI, body mass index.  
*RRs (95% CI) were fully adjusted for womens year of birth, age, education level, smoking status, age at menarche, number of children, age at first birth, menopausal status/timing 
and hormone therapy at baseline.   
 
 
 
 
This article is protected by copyright. All rights reserved.
A
cc
ep
te
d
 A
rt
ic
le
For Review
 O
nly



	





This article is protected by copyright. All rights reserved.
